Testing a Cancer-Fighting Virus With a PD-1 Drug for High-Grade Glioma That Came Back
Original title: A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early first test in people, so it is a long way from being regular care.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This trial is testing whether a virus made to attack tumors, given with a PD-1 drug, can help people whose high-grade glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary has come back.
Who this trial is for. This trial is for people with a high-grade glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary that has come back after earlier treatment. It tests a new tumor-fighting virus called Ad-TD-nsIL12 together with a PD-1 inhibitor. Everyone in the study gets the same treatment.
Where it stands. There are no results yet. The trial is set up to look at how well this combination works and how safe it is. Those answers are not in yet, and the trial has not reported any findings.
What this means, and what it doesn't
What it could mean: Nothing is proven here yet. If your glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary has come back and you want to know about trial options, you can ask your care team about this one. They can tell you if it makes sense to look into.
What it doesn't mean: This does not mean there is a new treatment ready for patients. A trial is a test, not proven care. Being in a trial is not a guarantee that it will help you. It is not a promise of a cure. The treatment may not work, and it may cause side effects.
Source: ClinicalTrials.gov, July 14, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.